• Startseite
• lx arp1
• The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway, Journal of Translational Medicine

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway, Journal of Translational Medicine

4.8 (389) · € 14.99 · Auf Lager

PDF) Norcantharidin triggers apoptotic cell death in non-small cell lung cancer via a mitophagy-mediated autophagy pathway

Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma - ScienceDirect

MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis - Trang T. Pham, Steven P. Angus, Gary L. Johnson, 2013

Cancers, Free Full-Text

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway, Journal of Translational Medicine

Biomolecules, Free Full-Text

Frontiers Expanding role of deoxyribonucleic acid-sensing mechanism in the development of lifestyle-related diseases

文献高级检索结果

AG Hari Gorantla

TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis

Structure of active ingredients in Mylabris and related antitumor

Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma - ScienceDirect

TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway, Journal of Translational Medicine